| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Stages | Expansion, Later Stage |
| Investing | United States • Switzerland • Europe |
| Investment Range | $1,000,000 - $500,000,000 |
| Assets Under Management | $500,000,000 |
BB BIOTECH Ventures is a venture capital firm with a strong focus on the healthcare sector. With headquarters in Ksnacht / Zurich, Switzerland, the firm is dedicated to investments in companies that are in the process of developing and marketing innovative drugs and medical devices.
The firm operates with an investment minimum of 1 million and can invest up to 500 million, targeting companies at the expansion and later stages of their development. As a venture capital fund, BB BIOTECH Ventures operates with a specialization in equity investments and has assets under management amounting to 500 million.
The Guernsey-based fund benefits from the advisory services of the Bellevue Asset Management Group, which has a presence in Curaao, Boston/USA, and Kusnacht/Zurich. The experienced team of investment advisors is supported by an advisory board, healthcare investment experts, and a broad network of industry specialists and advisors. The aim of BB BIOTECH Ventures is to maximize the returns to their investors through a combination of hard work, extensive experience, networking, and a focus on value creation.
Due to the nature of their specialized investment thesis, BB BIOTECH Ventures has a propensity for engaging with companies poised to make significant impacts on the healthcare and biotechnology sectors.









